LP
Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
126
AnaptysBio
ANAB
$613M
|
DR
David Risinger
| $21.90 | $47 |
115%
upside
| Outperform | 1 year ago |
|
127
MindMed
MNMD
$702M
|
RL
Rudy Li
| $9.22 | $20 |
117%
upside
| Outperform | 1 year ago |
|
|
LENZ
128
LENZ Therapeutics
LENZ
$1.2B
|
MG
Marc Goodman
| $41.98 | $32 |
24%
downside
| Outperform | 1 year ago |
|
129
Ardelyx
ARDX
$1.57B
|
RR
Roanna Ruiz
| $6.52 | $14 |
115%
upside
| Outperform | 1 year ago |
|
130
Larimar Therapeutics
LRMR
$337M
|
JP
Joori Park
| $3.94 | $25 |
535%
upside
| Outperform | 1 year ago |
|
131
Labcorp
LH
$23.2B
|
MC
Michael Cherny
| $278.67 | $260 |
7%
downside
| Outperform | 1 year ago |
|
132
GoodRx Holdings
GDRX
$1.39B
|
MC
Michael Cherny
| $4 | $8 |
100%
upside
| Outperform | 1 year ago |
|
133
Certara
CERT
$1.69B
|
MC
Michael Cherny
| $10.52 | $19 |
81%
upside
| Market Perform | 1 year ago |
|
134
Henry Schein
HSIC
$8.42B
|
MC
Michael Cherny
| $69.43 | $78 |
12%
upside
| Market Perform | 1 year ago |
|
135
Teladoc Health
TDOC
$1.38B
|
MC
Michael Cherny
| $7.82 | $17 |
117%
upside
| Market Perform | 1 year ago |
|
136
enGene Holdings
ENGN
$265M
|
MF
Mani Foroohar
| $5.18 | $31 |
498%
upside
| Outperform | 1 year ago |
|
137
BrightSpring Health Services
BTSG
$4.27B
|
WM
Whit Mayo
| $24.13 | $15 |
38%
downside
| Outperform | 1 year ago |
|
138
United Therapeutics
UTHR
$18.1B
|
RR
Roanna Ruiz
| $400.52 | $330 |
18%
downside
| Outperform | 1 year ago |
|
139
Neuropace
NPCE
$322M
|
MK
Mike Kratky
| $9.73 | $22 |
126%
upside
| Outperform | 1 year ago |
|
140
Incyte
INCY
$16.9B
|
AB
Andrew Berens
| $86.64 | $78 |
10%
downside
| Outperform | 1 year ago |
|
|
NBTX
141
Nanobiotix
NBTX
$419M
|
JC
Jonathan Chang
| $8.70 | $11 |
26%
upside
| Outperform | 1 year ago |
|
|
ABVX
142
Abivax
ABVX
$6.65B
|
TS
Thomas Smith
| $88.03 | $20 |
77%
downside
| Outperform | 1 year ago |
|
143
Insulet
PODD
$24.5B
|
MK
Mike Kratky
| $348.43 | $184 |
47%
downside
| Outperform | 1 year ago |
|
144
Vericel Corp
VCEL
$1.72B
|
MK
Mike Kratky
| $34.05 | $42 |
23%
upside
| Outperform | 1 year ago |
|
145
Intuitive Surgical
ISRG
$167B
|
MK
Mike Kratky
| $466.86 | $342 |
27%
downside
| Outperform | 1 year ago |
|
146
Edwards Lifesciences
EW
$47.5B
|
MK
Mike Kratky
| $80.94 | $75 |
7%
downside
| Market Perform | 1 year ago |
|
147
Procept Biorobotics
PRCT
$2.26B
|
MK
Mike Kratky
| $40.68 | $37 |
9%
downside
| Outperform | 1 year ago |
|
148
Axogen
AXGN
$735M
|
MK
Mike Kratky
| $15.98 | $9 |
44%
downside
| Outperform | 1 year ago |
|
149
Amgen
AMGN
$153B
|
DR
David Risinger
| $283.64 | $318 |
12%
upside
| Outperform | 1 year ago |
|